New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
14:01 EDTPTCTPTC Therapeutics announces expanded access program for Translarna
PTC Therapeutics announced the initiation of a reimbursed expanded access program, or EAP. PTC's EAP program is intended to make Translarna available to patients before commercial availability in certain countries. Where mechanisms exist and in accordance with local regulations, PTC will make Translarna available to nonsense mutation Duchenne muscular dystrophy patients through funded EAP programs.
News For PTCT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
11:37 EDTPTCTPTC Therapeutics CEO no longer owns company shares, TheStreet says
PTC Therapeutics CEO Stu Peltz sold the remaining 47,200 shares he owned in the company, TheStreet's Adam Feuerstein reports, citing a regulatory filing yesterday. The sale follows a stock rise in part fueled by takeover speculation, Feuerstein adds. Reference Link
March 19, 2015
08:11 EDTPTCTPTC Therapeutics and University of Pennsylvania partner for disease research
Subscribe for More Information
March 13, 2015
19:13 EDTPTCTPTC Therapeutics has a conference call hosted by JPMorgan
JPMorgan Analyst Kasimov will host a conference call with CEO Stuart Peltz and CFO Shane Kovacs on March 18 at 10 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use